Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 368-374, April 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Homburger, F.
Right arrow Articles by Warner, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Homburger, F.
Right arrow Articles by Warner, S.

Experimental Chemotherapy in Chemically Induced Mouse Tumors and Their Transplants*

F. Homburger, A. B. Russfield, J. R. Baker, A. Tregier, R. Kenney, C. Crooker, H. Rys and S. Warner

( Bio-Research Institute, Cambridge, Massachusetts)

Uniform subcutaneous fibrosarcomas can be induced by single injections of 3,4,9,10-dibenzpyrene into C57BL/6 mice at the rate of 200–300 tumors per week from a colony of approximately 3,000 animals (8) and are practical for chemotherapy screening as shown by their response to five different chemotherapeutic agents previously tested in transplanted tumors. The animals are safe, since no carcinogen is excreted. Histology showed more marked responses (reduced mitoses, fibrosis) in induced than in transplanted tumors. Chemotherapy with thioTEPA administered during the induction period or latent phase caused significant delays in the appearance of tumors, which is analogous to the tumor-inhibiting effect claimed clinically for thioTEPA when administered after radical surgery for breast cancer.

* Supported in part by USPHS Grant CY-4869.

Received 10/30/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.